755039-90-8 (环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式,Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-, cis-)

CAS号:
755039-90-8
中文名称:
环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式
英文名称:
Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-, cis-
分子式:
C14H27N3
分子量:
237.384283304214

环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式(755039-90-8)名称与标识符

名称

中文别名:
(1S,4S)-4-(4-(环丙基甲基)哌嗪-1-基)环己胺;顺式-4-[4-(环丙基甲基)-1-哌嗪]-环己胺;环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式;
英文别名:
Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-, cis-;cis-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexanamine;(3,4-dihydro-1(2H)-benzopyran-4-yl)ethanoic acid;(chroman-4-yl)acetic acid;(cis)-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexanamine;2-(3,4-dihydro-2H-1-benzopyran-4-yl)acetic acid;2-(chroman-4-yl)acetic acid;2H-1-Benzopyran-4-acetic acid,3,4-dihydro;cis-4-(4-cyclopropylmethyl-piperazin-1-yl)-cyclohexylamine;1201771-57-4;SCHEMBL372638;4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexan-1-amine;4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexanamine;4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexan-1-amine;BCP18570;BKB46131;CS-B0209;AKOS012103565;cis-4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexanamine;(trans)-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexanamine;LBYALFWGJOLWMN-UHFFFAOYSA-N;SCHEMBL842660;CS-B0208;trans-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexanamine;(1s,4s)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexanamine;CS-13985;4-(4-cyclopropylmethyl-piperazin-1-yl)-cyclohexylamine;SCHEMBL15082472;SCHEMBL372637;SCHEMBL736461;Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-, trans-;Cyclohexanamine,4-[4-(cyclopropylmethyl)-1-piperazinyl]-,cis-;LBYALFWGJOLWMN-OKILXGFUSA-N;cis-4-(4-cyclopropylmethyl-piperazin-1-vi)-cyclohexylamine;SB17642;LBYALFWGJOLWMN-HDJSIYSDSA-N;876461-31-3;AKOS037649971;trans-4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexanamine;AM806742;(1r,4r)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexanamine;755039-90-8;trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexanamine;DB-266993;

标识符

MDL:
MFCD13184578
InChIKey:
LBYALFWGJOLWMN-UHFFFAOYSA-N
Inchi:
1S/C14H27N3/c15-13-3-5-14(6-4-13)17-9-7-16(8-10-17)11-12-1-2-12/h12-14H,1-11,15H2
SMILES:
N1(CCN(CC1)CC1CC1)C1CCC(CC1)N

环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式(755039-90-8)物化性质

实验特性

  • LogP : 1.86000
  • PSA : 32.50000
  • 沸点 : 326.1±10.0 °C at 760 mmHg
  • 蒸气压 : 0.0±0.7 mmHg at 25°C
  • 闪点 : 148.9±13.8 °C
  • 密度 : 1.1±0.1 g/cm3

计算特性

  • 精确分子量 : 237.22000
  • 氢键供体数量 : 1
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 3
  • 同位素质量 : 237.220497874g/mol
  • 重原子数量 : 17
  • 复杂度 : 236
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.2
  • 拓扑分子极性表面积 : 32.5Ų

环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式(755039-90-8)国际标准相关数据

EINECS:

环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式(755039-90-8)推荐厂家 更多厂家(6)

环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式(755039-90-8)上下游

环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-顺式(755039-90-8)参考资料

Reaxys RN:
PubChem CID: